Education
About Us
Working with TipRanks
Follow Us
Mochida Pharmaceutical Co., Ltd. (JP:4534)
:4534
RESEARCH TOOLSreports
4534 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥2,836.00 - ¥3,625.00
Previous CloseN/A
Volume18.00K
Average Volume (3M)20.82K
Market Cap
€110.76B
Enterprise Value¥51.25B
Total Cash (Recent Filing)€51.15B
Total Debt (Recent Filing)€342.00M
Price to Earnings (P/E)18.9
Beta0.53
Next Earnings
Oct 31, 2025EPS EstimateN/A
Next Dividend Ex-Date
Sep 29, 2025Dividend Yield2.46%
Share Statistics
EPS (TTM)53.43
Shares Outstanding36,390,000
10 Day Avg. Volume17,530
30 Day Avg. Volume20,820
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€3,459.60Price Target Upside6.29% Upside
Rating ConsensusHold
Number of Analyst Covering0
Mochida Pharmaceutical Co., Ltd. News
4534 FAQ
What was Mochida Pharmaceutical Co., Ltd.’s price range in the past 12 months?
Mochida Pharmaceutical Co., Ltd. lowest stock price was ¥2836.00 and its highest was ¥3625.00 in the past 12 months.
What is Mochida Pharmaceutical Co., Ltd.’s market cap?
Mochida Pharmaceutical Co., Ltd.’s market cap is €110.76B.
When is Mochida Pharmaceutical Co., Ltd.’s upcoming earnings report date?
Mochida Pharmaceutical Co., Ltd.’s upcoming earnings report date is Oct 31, 2025 which is in 40 days.
How were Mochida Pharmaceutical Co., Ltd.’s earnings last quarter?
Mochida Pharmaceutical Co., Ltd. released its earnings results on Aug 01, 2025. The company reported ¥53.43 earnings per share for the quarter, beating the consensus estimate of N/A by ¥53.43.
Is Mochida Pharmaceutical Co., Ltd. overvalued?
According to Wall Street analysts Mochida Pharmaceutical Co., Ltd.’s price is currently Undervalued.
Does Mochida Pharmaceutical Co., Ltd. pay dividends?
Mochida Pharmaceutical Co., Ltd. pays a Semiannually dividend of ¥40 which represents an annual dividend yield of 2.46%. See more information on Mochida Pharmaceutical Co., Ltd. dividends here
What is Mochida Pharmaceutical Co., Ltd.’s EPS estimate?
Mochida Pharmaceutical Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Mochida Pharmaceutical Co., Ltd. have?
Mochida Pharmaceutical Co., Ltd. has 36,390,000 shares outstanding.
What happened to Mochida Pharmaceutical Co., Ltd.’s price movement after its last earnings report?
Mochida Pharmaceutical Co., Ltd. reported an EPS of ¥53.43 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 4.362%.
Which hedge fund is a major shareholder of Mochida Pharmaceutical Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4534
Company Description
Mochida Pharmaceutical Co., Ltd.
Mochida Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company that focuses on the research, development, manufacturing, and marketing of prescription drugs, particularly in the fields of neurology, psychiatry, and urology. Established in 1949, Mochida has a diverse portfolio of products that include innovative therapeutic agents, generics, and over-the-counter medications. The company is dedicated to improving patient care through advanced medical solutions and has a strong presence in both domestic and international markets.
Technical Analysis
Kaken Pharmaceutical Co
―
Kissei Pharmaceutical Co
―
Towa Pharmaceutical Co
―
KYORIN Pharmaceutical Co.,Ltd.
―
ASKA Pharmaceutical Holdings Co., Ltd.
―
Options Prices
Currently, No data available
---